CVAC Wellness Systems Has Developed a Natural Method for Enhancing Physical Condition
CVAC Wellness Systems will be presenting its products and technologies at OneMedForum SF 2012, on January 9 – 12
Featured Articles
BMEYE Products Provide Fast, Easily Obtained Diagnosis to Improve Patient Care
The company has developed two products that have been given approval to be marketed by U.S. and European regulatory agencies
MPR Executives Lend Insight on Compressing Product Development in the Medical Devices Field
Christian Haller and Eric Claude discuss the process of “going slow in order to go fast.”
This Week in Diagnostics
Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.
China Forum II includes prominent Chinese and US executives active in the rapidly developing marketplace in China
The rapid growth of the middle class in China represents an unusual opportunity because of the strong desire for western technology.
QLida To Present Heart Attack Detection Technology at OneMedForum SF 2012
Michael Boyce-Jacino, CEO and Founder of Qlida, talks with OneMedRadio about the technology behind his brainchild.
Kimberly Ha of BioPharm Insight Identifies Disruptive Trends and Technologies in Biotechnology
Kimberly Ha notes that many big pharma companies are partnering with academic institutions and that oncology, followed by neurology is one of the hottest areas in acquisitions
This Week In Diagnostics
Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.
WNDM to Acquire Medical Device Distributor Juventas; Bryant Gaines Named WNDM COO Effective Immediately
Wound Management Technologies, Inc. has signed a letter of intent to acquire Juventus LLC. which operates a nationwide distributor network.
EpiCept’s Ceplene Product Receives Marketing Auth. by European Commission
Ceplene is administered for maintenance of first remission in patients with AML, the most common type of Leukemia in adults.